AI-tool for prostate pathology at St. Olavs Hospital Trust

Information

4/24/2025 9:22 AM (GMT+02:00)
7/4/2025 12:00 PM (GMT+02:00)
No
No

Buyer

SYKEHUSINNKJØP HF SYKEHUSINNKJØP HF
Frida Rekstad Frida Rekstad
Postboks 40
Tollbugata 7

9811 VADSØ
Norway
916879067

Short description

Helse Midt-Norge (Central Norway Health Authority) is the first region in Norway to use digital pathology for routine diagnostics in pathology.

The two pathology departments, St. Olavs Hospital and Ålesund sykehus, use the same scanners (Hamamatsu and Philips), the same laboratory information and management system (LIMS, Sympathy) and image management system (IMS, Philips).

Currently many different AI tools and image analyses software packages have been CE-IVD approved for use in clinical routine practice, but until now very few pathology departments have implemented these computer-aided diagnostic (CAD) tools in daily clinical practice.

The two pathology departments in Helse Midt-Norge aim to implement AI tools to enhance the efficiency, speed and objectivity of pathology diagnostics. More importantly, patients will benefit from superior tissue diagnostics that forms the basis for personalized treatment.

To start the AI-tool journey the short-term goal is to purchase and implement an AI tool for automatic detection and grading of prostate cancer. Helse Midt-Norge’s IT organisation, Hemit HF, will be an important partner for successful integration with our IMS.

This is the second step in a two-step tender. If you want to see the qualification step and access qualification documents, please follow this link: Qualification: AI-tool for prostate pathology at St. Olavs Hospital Trust

Mercell Holding AS

Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.

Contact us

Write to us

+47 21 01 88 00